Delivery Order SPE2DB20D1004-SPE2DB23FF4W8

Award Date 3/21/23
Potential Completion Date 3/22/23
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of the pharmaceutical product Trulicity (3 mg/0.5 ml pen, 0.5 ml) to the Defense Logistics Agency (DLA). The $2,543.34 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 22, 2023, with a completion date of December 26, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of the pharmaceutical product Trulicity (1.5 mg/0.5 ml pen, 0.5 ml) to the Defense Logistics Agency (DLA). The $7,940.12 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on November 6, 2024. The contract has a period of performance through November 7, 2024 and was not designated with a set-aside requirement. AmerisourceBergen holds a $999,999,999...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of the prescription drug Trulicity (3 mg/0.5 ml pen) to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,757.66, is a delivery order issued under an existing Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, which has a ceiling value of up to $999,999,999 and runs through December 2025. This IDC enables the DLA to...
This federal contract award has been granted to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA). The contract is for the delivery of Trulicity 3 mg/0.5 ml pen 0.5 ml, a prescription medication, to DLA facilities supporting the Department of Defense (DoD) worldwide. The contract, valued at $1,741.68, is a delivery order awarded under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the pharmaceutical product Trulicity 4.5 mg/0.5 ml pen, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract has a ceiling value of $1,741.68 and a performance period through April 12, 2023. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC is valued at up to...
This federal contract award is for the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen 0.5 ml, with a ceiling value of $10,266.17. The award was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is January 28, 2025. The contract is not designated with a set-aside...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Trulicity 1.5 mg/0.5 ml pen 0.5ml. The award, valued at $8,853.30, is a delivery order under an indefinite delivery contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical program. This IDC, worth up to $999,999,999 through December 2025, enables the DLA to efficiently procure a comprehensive range of medical...
This federal contract award is for the delivery of the pharmaceutical product Trulicity (0.75 mg/0.5 ml pen, 0.5 ml) to the Defense Logistics Agency (DLA). The $1,741.68 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and medical supply provider to the U.S. government. The contract is a delivery order issued under Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through...
This federal contract award is for the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen 0.5 ml, with a ceiling value of $5,825.04. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order with a firm fixed price, and the ultimate completion date is May 3, 2023. This contract is not designated as a set-aside, indicating open competition....
This federal contract award is for the supply of the medication Trulicity (1.5 mg/0.5 ml pen, 0.5 ml) to the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract, with a ceiling value of $14,229.96, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order, with a firm fixed price pricing type, and a completion date of November 29, 2021. It is not designated as a set-aside contract....
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB23FF4W8
    Delivery Order

This federal contract award is for the supply of the pharmaceutical drug Trulicity (1.5 mg/0.5 ml pen, 0.5 ml) to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on March 21, 2023, with a ceiling value of $1,339.26 and a completion date of March 22, 2023. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 12:00 PM